ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,010Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 1844

$471K Total Retail Price of All Prescriptions

Rank: 405 out of 1844

480 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 6,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 734 441 S3 1 2
LISINOPRIL 312 215 2 4
LEVOTHYROXINE SODIUM 306 252 3 1
SIMVASTATIN 288 223 4 3
METFORMIN HCL 279 200 5 8
ZOLPIDEM TARTRATE 217 130 6 23
OMEPRAZOLE 215 128 7 5
HYDROCHLOROTHIAZIDE 174 136 8 9
FUROSEMIDE 170 154 9 7
METOPROLOL TARTRATE 166 120 10 11
LOVASTATIN 158 102 11 44
ATENOLOL 150 103 12 17
GABAPENTIN 147 71 13 15
AMLODIPINE BESYLATE 146 146 14 6
MELOXICAM 141 95 15 28
NEXIUM 139 75 16 31
RANITIDINE HCL 134 81 17 38
FLUOXETINE HCL 120 63 18 41
CYCLOBENZAPRINE HCL 119 42 R 19 53
SERTRALINE HCL 115 65 20 21
CITALOPRAM HBR 107 62 21 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 84 22 20
TAMSULOSIN HCL 103 87 23 27
CEPHALEXIN 96 78 24 56
METOPROLOL SUCCINATE 94 74 25 14
GLIPIZIDE 84 68 26 70
KLOR-CON M20 82 65 27 54
SPIRONOLACTONE 81 67 28 60
WARFARIN SODIUM 79 67 29 13
ADVAIR DISKUS 75 42 30 51
PRAVASTATIN SODIUM 74 70 31 10
NABUMETONE 74 48 31 158
CRESTOR 73 35 33 30
ALLOPURINOL 71 60 34 29
POTASSIUM CHLORIDE 70 51 35 16
ALENDRONATE SODIUM 69 58 36 25
OXYCODONE-ACETAMINOPHEN 69 39 S2 36 94
TRAMADOL HCL 68 52 38 18
PREDNISONE 67 53 39 40
LOSARTAN POTASSIUM 67 62 39 24
ATORVASTATIN CALCIUM 65 64 41 12
DOXYCYCLINE HYCLATE 64 46 42 90
BUMETANIDE 61 51 43 121
PANTOPRAZOLE SODIUM 61 61 43 32
METHOCARBAMOL 60 33 R 45 241
CARVEDILOL 60 53 45 22
VERAPAMIL ER 59 56 47 98
IBUPROFEN 58 42 48 89
AZITHROMYCIN 57 41 49 37
OXYCODONE HCL-ACETAMINOPHEN 55 0 S2 50 83
OXYCONTIN 55 16 S2 50 144
GEMFIBROZIL 55 27 50 108
AMOXICILLIN 54 41 53 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.